secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001628280-25-001246
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx reports preliminary Q4 2024 net product sales: IBSRELA $54M, XPHOZAH $57M
--------------------------------------------------------------------------------

- IBSRELA net product sales: ~$54M in Q4 2024, ~$158M full year.
- XPHOZAH net product sales: ~$57M in Q4 2024, ~$161M full year.
- Cash, cash equivalents, and short-term investments: ~$250M as of Dec 31, 2024 (unaudited).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025001246/0001628280-25-001246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025001246/ardx-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-001246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer